TIX100 Safety Study in Healthy Volunteers
What You Need to Know Before You Apply
What is the purpose of this trial?
A Single Center, Single Dose, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires participants to be healthy without significant medical conditions or recent surgeries. It's best to discuss your specific medications with the trial team.
What safety data exists for TIX100 or similar treatments in healthy volunteers?
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 18-70 with a BMI of 18.5-29.9, no significant illnesses or surgeries in the last 12 weeks, and no history of neurological, cardiovascular, or other major diseases. Participants must not have used investigational drugs recently, abused substances, be pregnant/breastfeeding recently, or have had bariatric surgery within five years.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single dose of TIX100 or placebo to evaluate safety, tolerability, and pharmacokinetics
Follow-up
Participants are monitored for safety and pharmacokinetics after receiving the single dose
What Are the Treatments Tested in This Trial?
Interventions
- TIX100
Find a Clinic Near You
Who Is Running the Clinical Trial?
TIXiMED, Inc.
Lead Sponsor